Table 3.
Genotype distributions of rs7779972 between VKH case and control groups
| Genotype | VKH | Controls | P | OR (95% CI) |
|---|---|---|---|---|
| n (%) | n (%) | |||
| First | ||||
| AA | 47(12.6) | 25(6.6) | 0.005 | 2.059(1.239–3.422) |
| AG | 168(45.2) | 160(42.0) | 0.381 | 1.138(0.853–1.518) |
| GG | 157(42.2) | 196(51.4) | 0.011 | 0.689(0.517–0.919) |
| Second | ||||
| AA | 44(12.1) | 45(8.7) | 0.110 | 1.429(0.921–2.216) |
| AG | 170(46.6) | 222(41.2) | 0.320 | 1.147(0.876–1.502) |
| GG | 151(41.4) | 247(48.1) | 0.050 | 0.763(0.582-1.000) |
| Combined | ||||
| AA | 91(12.3) | 70(7.8) | 2.28 × 10− 3 | 1.660(1.196–2.305) |
| AG | 338(45.9) | 382(42.7) | 0.198 | 1.138(0.935–1.384) |
| GG | 308(41.8) | 443(49.5) | 1.88 × 10 − 3 | 0.733(0.602–0.892) |
VKH: Vogt-Koyanagi-Harada Disease; OR: Odd ratios; 95% CI :95% confidence interval
P: P-value which was calculated by χ2 test lower than 2.08 × 10− 3 (0.05/24) has statistical significance, and indicated by boldface